Trusted Supply of Critical & Orphan Medicines, Worldwide!

Drug: Sorafenib
Brand: Nexavar 200mg
Manufacturer /
TM Owner
Bayer
Origin: Germany / India

Nexavar 200mg Tablet

Nexavar delivers Sorafenib as a targeted kinase inhibitor. It blocks specific enzymes that drive cancer cell growth and survival, offering a precision alternative to conventional chemotherapy. It is used in the treatment of a range of cancers. It is supplied as a tablet (200mg). Its targeted profile makes it a valued choice in contemporary clinical practice.
Strength: 200mg
Pack Size: 60s
Storage: 20°C to 25°C
Form: Tablet

+91 900 500 9556

Global Shipping : Reliable Global Distribution Network

Express Delivery : Priority Shipping for Every Order

Secure Payments : Trusted Payment Protection System

Disclaimer
All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the 'Manufacturer/ TM Owner' section in compliance with statutory requirements. Read More

Secure Handling

24/7 Worldwide Support

Global Access

Worldwide Access to Health

Cold-Chain Expert

Excellence in Cold-Chain

Trusted Supply

Certified Medical Supply

Indications & Clinical Uses

  • Nexavar 200mg is a film-coated tablet containing sorafenib, a kinase inhibitor (targeted anticancer medicine), made by Bayer HealthCare Pharmaceuticals.
  • Under the US label it is used to treat unresectable hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and locally recurrent or metastatic, progressive differentiated thyroid carcinoma that no longer responds to radioactive iodine treatment.
  • The usual dose is 400 mg (two 200 mg tablets) twice daily, taken without food (at least 1 hour before or 2 hours after a meal).
  • Safety and effectiveness have not been established in children.
  • It is a prescription cancer medicine started and supervised by a specialist, and you take it yourself at home.
  • This review is based on the US label; local indications can differ.

Side Effects

  • The most common side effects (reported in 20% or more of patients) are diarrhea, fatigue, infection, hair loss (alopecia), hand-foot skin reaction (redness, pain or blistering of palms and soles, usually within the first six weeks), rash, weight loss, decreased appetite, nausea, stomach and abdominal pain, high blood pressure (hypertension) and bleeding (hemorrhage).
  • Serious reactions to report straight away include chest pain or shortness of breath (heart ischemia or infarction), serious bleeding, severe or persistent high blood pressure, severe skin reactions including Stevens-Johnson syndrome or toxic epidermal necrolysis, gastrointestinal perforation, QT prolongation (irregular heartbeat, fainting) and drug-induced liver injury.
  • The label carries no boxed warning.
  • Your team may reduce or pause the dose if side effects are severe.

Precautions & Warnings

  • Blood pressure is checked weekly during the first 6 weeks, then periodically.
  • Liver function tests, ECG and electrolytes are monitored, and thyroid-stimulating hormone (TSH) is checked monthly in thyroid cancer patients.
  • Nexavar can impair wound healing: withhold it for at least 10 days before elective surgery and wait at least 2 weeks after major surgery.
  • It is contraindicated in patients with known severe hypersensitivity to sorafenib or any ingredient, and in combination with carboplatin and paclitaxel in squamous cell lung cancer.
  • It can cause fetal harm: females who can become pregnant should have a pregnancy test and use effective contraception during treatment and for 6 months after the last dose, and males for 3 months.
  • Do not breastfeed during treatment and for 2 weeks after the last dose.
  • Store at 20°C to 25°C in a dry place.

Avoid Interactions

  • Medicines that increase risk: warfarin (monitor INR and watch for bleeding) and other medicines known to prolong the QT/QTc interval, which should be avoided with Nexavar.
  • Medicines that reduce sorafenib exposure: strong CYP3A4 inducers such as rifampin (lowers sorafenib exposure by about 37%), which should be avoided, and the antibiotic neomycin, which lowers exposure by about 54% and should be avoided.
  • Take Nexavar on an empty stomach as directed.
  • Tell your healthcare provider about all prescription, non-prescription and herbal medicines and supplements you use, since some may need to be stopped or adjusted.

References

Frequently Asked Questions

Nexavar (sorafenib) 200 mg tablets treat liver cancer (unresectable hepatocellular carcinoma), advanced kidney cancer (renal cell carcinoma) and progressive differentiated thyroid cancer that no longer responds to radioactive iodine. It is a targeted cancer medicine that a cancer specialist prescribes, and you take it yourself at home.

Simple Working Process

We have simplified the online drug ordering process into 4 easy steps to ensure
a safe, secure, and hassle-free experience for our customers.


Order Online

Place your order online and upload prescription in minutes with ease.



Order Confirmation

We verify your prescription and confirm your order quickly and securely.



Prescription Review

Reviewed by licensed pharmacists. Carefully processed and validated.

R

Receive Medicines

Approved order delivered fast, easy, and right to your doorstep or nearby Airport.



Global Standards. Trusted Care.

Trusted & Reliable – Your Partner in Global Distribution.

We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.